N-Acetylcysteine (NAC) may help to reduce skin-picking behavior in some people with Prader-Willi syndrome (PWS), but many patients do…
Articles by Marisa Wexler, MS
A class of medications called GLP-1 receptor agonists (GLP1-RA) may help reduce appetite and promote weight loss for people with…
Excessive eating in Prader-Willi syndrome (PWS) increases the risk of mortality not only by making patients prone to obesity…
During pregnancy, Prader-Willi syndrome (PWS) may manifest as an excess of fluid around the developing fetus coupled with restricted…
People with Prader-Willi syndrome (PWS) have smaller pituitary glands than their typically-developing peers, according to data from a small…
Aardvark Therapeutics has raised $29 million in financing to help support three planned Phase 2 clinical trials of its…
Eurordis opened a campaign, called Rare 2030 Action, that is seeking to establish a European action plan for…
People with Prader-Willi syndrome (PWS) and other diseases commonly experience sleep problems, and the problems are rarely addressed effectively…
Specific genetic subtypes and growth hormone use both influence the physical characteristics, such as head shape and eye appearance, of…
Soleno Therapeutics has partnered with Vanderbilt University to develop therapies that work as ATP-dependent potassium channel activators for rare diseases,…